1. Home
  2. PFSI vs GKOS Comparison

PFSI vs GKOS Comparison

Compare PFSI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSI
  • GKOS
  • Stock Information
  • Founded
  • PFSI 2008
  • GKOS 1998
  • Country
  • PFSI United States
  • GKOS United States
  • Employees
  • PFSI N/A
  • GKOS N/A
  • Industry
  • PFSI Finance: Consumer Services
  • GKOS Medical/Dental Instruments
  • Sector
  • PFSI Finance
  • GKOS Health Care
  • Exchange
  • PFSI Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • PFSI 5.3B
  • GKOS 5.8B
  • IPO Year
  • PFSI 2013
  • GKOS 2015
  • Fundamental
  • Price
  • PFSI $97.28
  • GKOS $87.48
  • Analyst Decision
  • PFSI Buy
  • GKOS Strong Buy
  • Analyst Count
  • PFSI 7
  • GKOS 12
  • Target Price
  • PFSI $119.57
  • GKOS $131.17
  • AVG Volume (30 Days)
  • PFSI 457.3K
  • GKOS 1.1M
  • Earning Date
  • PFSI 07-22-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • PFSI 1.23%
  • GKOS N/A
  • EPS Growth
  • PFSI 97.42
  • GKOS N/A
  • EPS
  • PFSI 7.22
  • GKOS N/A
  • Revenue
  • PFSI $3,571,340,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • PFSI N/A
  • GKOS $27.88
  • Revenue Next Year
  • PFSI $18.11
  • GKOS $27.76
  • P/E Ratio
  • PFSI $13.53
  • GKOS N/A
  • Revenue Growth
  • PFSI 65.89
  • GKOS 26.70
  • 52 Week Low
  • PFSI $85.74
  • GKOS $77.10
  • 52 Week High
  • PFSI $119.13
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • PFSI 46.50
  • GKOS 30.16
  • Support Level
  • PFSI $92.95
  • GKOS $82.88
  • Resistance Level
  • PFSI $96.10
  • GKOS $97.76
  • Average True Range (ATR)
  • PFSI 2.51
  • GKOS 3.08
  • MACD
  • PFSI -0.66
  • GKOS -1.35
  • Stochastic Oscillator
  • PFSI 31.32
  • GKOS 26.36

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: